|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.39 EUR | -0.71% |
|
-3.47% | -65.25% |
Sequana Medical NV reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 0.384173 million compared to EUR 0.464446 million a year ago. Net loss was EUR 16.46 million compared to EUR 14.86 million a year ago.
Basic loss per share from continuing operations was EUR 0.65 compared to EUR 0.68 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -65.25% | 53.29M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
SEQUANA MEDICAL N.V. 
